![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 36, 33319-33327, September 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
§,
¶, and
From the
Fondation pour Recherche Médicales,
University of Geneva, Geneva GE 1211, Switzerland
Received for publication, March 15, 2001, and in revised form, May 25, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Transcriptional elongation of many eukaryotic,
prokaryotic, and viral genes is tightly controlled, which contributes
to gene regulation. Here we describe this phenomenon for the MAP
kinase phosphatase 1 (MKP-1) immediate early gene. In rat GH4C1
pituitary cells, MKP-1 mRNA is rapidly and transiently induced by
the thyrotropin-releasing hormone (TRH) and the epidermal growth factor
EGF via transcriptional activation of the gene. Ca2+
signals are necessary for the induction of MKP-1 in response to TRH but
not to EGF. Reporter gene analysis with the newly cloned rat promoter
sequence shows only limited induction in response to various stimuli,
including TRH or EGF. By nuclear run-on assays we demonstrate that in
basal conditions, a strong block to elongation in the first exon
regulates the MKP-1 gene and that stimulation with either TRH or EGF
overcomes the block. Ca2+ signals are important to release
the MKP-1 elongation block in a manner similar to the c-fos
oncogene. These results suggest that a common mechanism of intragenic
regulation may be conserved between MKP-1 and c-fos in
mammalian cells.
Long term cellular processes such as proliferation,
differentiation, and neuronal plasticity are controlled by
extracellular stimuli and require the synthesis of new gene products.
Following stimulation, expression of immediate early genes
(IEGs) precedes the expression of late
response genes, the latter encoding for proteins implicated in specific
functions. The best known IEG products are transcription factors such
as c-Fos, c-Jun, and c-Myc, which control the expression of late
response genes (1, 2). Not all IEGs encode for transcription factors.
For instance, structural proteins like actin or tropomyosin, cytokines,
and other regulatory proteins show a rapid and transient induction by
growth factors (1).
Recently, a group of dual specificity phosphatases have been identified
as being IEG products induced by various stimuli (growth factors,
stress, neurotransmittors, etc.; reviewed in Ref. 3). These dual
specificity (threonine/tyrosine) phosphatases have been named MAP
kinase phosphatases (DSPs or MKPs), since they are effective in the
inactivation of MAP kinases by dual dephosphorylation (4). MAP kinase
phosphatase-1 (MKP-1/CL100/3CH134) is one example of this group of
nuclear enzymes encoded by an IEG. Although MKP-1 gene transcription is
activated by multiple signals, such as mitogens (5, 6), cytokines (7),
oxidative stress (8), heat shock (8), or hypoxia (9), the precise mode
of gene regulation of this immediate early gene by such stimuli remains
unclear. A comparison of the 5'-flanking sequence of the murine and the human genes revealed two conserved Ca2+/cAMP-responsive
elements (CREs) and one E box motif in the promoter region of MKP-1.
Recently, the upstream stimulatory factor, a member of the
basic/helix-loop-helix/leucine zipper family has been shown to
bind to the E box motif and transactivate MKP-1 expression in synergy
with protein kinase A (10). Since multiple intracellular signals can
target MKP-1 gene expression, it is likely that regulatory elements
other than the CREs and the E box motifs may influence its
transcription. Alternatively, additional regulation at the level of
transcriptional elongation, termination, and/or mRNA stability may
be important to control MKP-1 gene expression.
Regulation of gene expression at the level of transcriptional
elongation is well established in prokaryotes and in an increasing number of eukaryotic genes (11, 12). Earlier studies in mammalian cells
have reported that the IEGs c-fos, c-myc, hsp70,
and tumor necrosis factor- Here we show a rapid and massive increase in MKP-1 mRNA triggered
by either thyrotropin-releasing hormone (TRH) or epidermal growth
factor (EGF) in GH4C1 neuroendocrine cells. Ca2+ signals
are necessary for the induction of MKP-1 gene expression in response to
TRH but not to EGF. After cloning the rat MKP-1 genomic fragment, we
demonstrate by a reporter gene assay that activity of the MKP-1
promoter alone cannot explain induction of MKP-1 expression in GH4C1
cells. Using nuclear run-on experiments, we show that control of MKP-1
transcription involves a block to elongation in the first exon. This
block represents a decisive element in the regulation of MKP-1 gene expression.
Materials--
The thyrotropin-releasing hormone TRH (Roche
Molecular Biochemicals) and the epidermal growth factor EGF (Sigma)
were diluted in H2O at 27.6 mM and stored in
aliquots at Cell Culture and Stimulation--
GH4C1 pituitary cells were
maintained in Ham's F-10 medium (Life Technologies, Inc.) supplemented
with 2.5% fetal bovine serum and 15% horse serum at 37 °C in a
humidified atmosphere with 5% CO2. Confluent GH4C1 cells
were incubated in Ham's F-10 serum-free medium (SFM) containing 5 µg/liter transferrin for 24 h and then stimulated for the
indicated time with either 100 nM TRH or 10 nM
EGF. When indicated, 0.6 mM EGTA was added to the medium 5 min before TRH or EGF stimulation to chelate free extracellular calcium
([Ca2+]e <0.1 µM). Actinomycin D
(5 µg/ml) and cycloheximide (10 µg/ml) were added in SFM 30 min
before stimulation with either TRH or EGF; total RNA was isolated 30 min after TRH and EGF stimulation.
RNA Preparation, Northern Blot Analysis, and RNase Protection
Assay--
Total RNA was extracted from cells with an acid
phenol-guanidinium reagent (TRI-Reagent, Molecular Research Center,
Inc.) according to the manufacturer's instructions. RNA samples (10 µg) were denaturated by incubation in glyoxal, subjected to
electrophoresis in 1.2% agarose gels, and transferred to
Nylon-N+ membranes (Amersham Pharmacia Biotech) by
capillarity. mRNAs were detected by Northern blot hybridization in
a Church buffer with [
For the RNase protection assay, 20 µg of total RNA were hybridized
overnight in hybridization buffer (Ambion, Inc.) with 1.5 × 105 cpm of a riboprobe. After digestion with RNase A and
T1, samples were treated with proteinase K, phenol-extracted,
ethanol-precipitated, and analyzed on a 6% denaturating polyacrylamide
urea sequencing gel. The riboprobe was prepared from the rat MKP-1
cDNA (positions 15-301) subcloned in pGEM-T-easy (Promega).
Transcription with T7 of the SalI-linearized plasmid yielded
a probe of 395 nucleotides (nt), and a 286-nt protected fragment. As an
internal control for RNA loading, a GAPDH probe was included in the
hybridation mixture. The GAPDH plasmid (24), digested with
HinfI, produced a riboprobe of 185 nt and a 154-nt protected
band after RNase digestion. Autoradiographic signals detected in
Northern and RNase protection assays for MKP-1 were quantified in
arbitrary units using a PhosphorImager (Molecular Dynamics, Inc.) and
then normalized to the corresponding GAPDH values to correct variations
in RNA loading.
Detection of the transcriptional initiation site for the rat MKP-1 gene
was performed with a riboprobe prepared from the rat MKP-1 gene
(positions 607-807; GenBankTM accession number AF357203)
subcloned in pGEM-T-easy (Promega). Transcription with SP6 of the
BamHI linearized plasmid results in a riboprobe of 287 bp. A
sequencing ladder, corresponding to the antisense sequence of the probe
starting at 807, was resolved in parallel with the protected fragment.
The start site was determined relative to the probe sequence.
TaqMan RT-PCR--
Quantification of the MKP-1 mRNA was
performed by TaqMan RT-PCR (PerkinElmer Life Sciences) from the total
RNAs extracted from 10 series of GH4C1 cells cultured in nonstimulated
or stimulated conditions. Each RNA sample (diluted to 10 ng/µl) was
analyzed six times independently (replicas), and a standard curve was
included in each plate. The standard curve was prepared from the total RNA of a TRH-treated sample with a high level of expression of MKP-1,
diluted from 100 ng/µl to 1 pg/µl. Each dilution of the standard
sample was amplified in triplicate. 18 S rRNA was simultaneously amplified in each tube for normalization.
Briefly, 5 µl of each total RNA (corresponding to 50 ng of the
unknown samples), primed with random hexamers, were retrotranscribed into cDNA in a final volume of 30 µl using the TaqMan Gold RT-PCR Kit of PerkinElmer Life Sciences (PE N8080234), following the manufacturer's instructions. MKP-1 and 18 S rRNA were simultaneously amplified from each sample using 4 µl of the previous cDNA, 1× PerkinElmer's Universal PCR Master Mix (PE 4304437), 0.3× 18 S rRNA
Predeveloped Assay Reagent (PE 4310893E), 200 nM
MKP-1 forward primer 5'-CGCGCTCCACTCAAGTCTTC-3', 200 nM
MKP-1 reverse primer 5'-GGTGGACTGTTTGCTGCACA-3', and 250 nM
MKP-1 TaqMan probe 5'-FAM (6-carboxyfluorescein)-AGCCGAAAACGCTTCATATCCTCCTTGGTAMRA
(6-carboxytetramethylrhodamine)-3'. The primers and probe
for the quantification of MKP-1 were designed using Primer Express 1.0 software from PerkinElmer Life Sciences. These primers amplified an
87-bp fragment of the rat's MKP-1 gene comprising the exon 1-2
boundary, to avoid amplification of genomic DNA. The amplification and
quantification of MKP-1 and 18 S rRNA were performed using the ABI
PRISM 7700 Sequence Detection System of PerkinElmer Life Sciences,
using standard conditions. After fixing the base line in each
experiment and the threshold for each amplification, two different
values of threshold cycle were obtained for each replica: one for the
amplification of MKP-1 and another for the amplification of 18 S rRNA.
The relative quantities of MKP-1 and 18 S rRNA for each replica were
obtained by interpolating each threshold cycle value in the
corresponding standard curve. MKP-1 was then normalized to 18 S rRNA,
and the mean relative quantity and S.D. for each set of replicas in
each series were obtained. The mean relative quantity and S.D. of the
10 series were calculated, and values were expressed relative to basal levels.
Cloning of the Rat Gene--
The rat MKP-1 gene was amplified by
PCR from rat genomic DNA of GH4C1 cells using primers directed toward
two conserved regions in the promoter and exon 4 of the mouse and the
human gene: 5'-TCT TGC AAC CCT CCT CCC TTT G-3' (sense) and 5'-GTG GAA
CTC GGG AGG TGT TTG-3' (antisense). The resulting 2892-bp PCR fragment
was cloned, sequenced, and aligned to the mouse and human MKP-1 gene. The sequence of the rat MKP-1 gene in GH4C1 was compared and corrected according to sequences amplified in rat pancreatic
Southern blotting was performed with GH4C1 genomic DNA digested with
either StuI or PvuII restriction enzymes known to
cut in the exon 4. 20 µg of each digested DNA and the size marker Smart Ladder (Genetech) were subjected to electrophoresis in a 0.7%
agarose gel and transferred to Nylon-N+ membranes (Amersham
Pharmacia Biotech) by capillarity. The membranes were hybridized in
Church buffer with different random labeled [ Reporter Gene Assays--
GH4C1 cells maintained in culture
medium were detached from Petri dishes with trypsin, transiently
transfected using FuGENE 6 transfection reagent (Roche Molecular
Biochemicals), and seeded in 24-well multidishes (Falcon) at a density
of 6 × 104 cells/well. After 1 day, the medium was
replaced by SFM 24 h before exposure to the various stimuli. Cells
were stimulated with the addition of KCl, CPT-cAMP, TRH, and EGF
prediluted into SFM. Stimulation was performed for 3 h at 37 °C
and stopped by removal of the medium. Firefly luciferase activity was
determined according to Promega's Luciferase Reporter assay system
instructions. Cells were co-transfected with Renilla
luciferase expression plasmid to verify uniformity of transfection from
experiment to experiment.
Plasmid pMKP-1 was generated by cloning the region of the rat MKP-1
gene extending from Nuclear Run-on Transcription Assays--
GH4C1 cells in
nonstimulated or stimulated conditions for 25 min, as indicated, were
washed twice with phosphate-buffered saline (PBS) and detached with a
rubber policeman in lysis buffer (10 mM Tris·Cl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.5%
Nonidet P-40). Nuclei were isolated by centrifugation for 10 min at
300 × g and 4 °C, resuspended in lysis buffer, and
purified by centrifugation through a 5-ml cushion of 30% (w/w) sucrose
in lysis buffer. Isolated nuclei were resuspended in 100 µl of
storage buffer (50 mM Tris·HCl, pH 8.3, 40% glycerol, 5 mM MgCl2, 0.1 mM EDTA), quantified
to obtain 5 × 107 transcription-competent
nuclei per aliquot and stored at Rapid Induction of MKP-1 mRNA by TRH and EGF in Pituitary GH4C1
Cells Depends on Transcriptional Activation--
TRH elicits both
acute and long term responses in rat pituitary clonal growth hormone
(GH) cell types, leading to enhanced secretion of both prolactin
and GH (28, 29). Activation of prolactin gene transcription and long
term hormone secretion are preceded by the synthesis of the immediate
early gene products, c-fos, junB, and
c-jun, postulated to be involved in the regulation of the
prolactin gene. TRH stimulates the transient induction of these
immediate early genes via Ca2+-dependent
mechanisms (30-32).
MKP-1, originally identified as an immediate early gene product, is
induced by mitogens (5, 6), heat shock, or oxidative stress (8) and
also by Ca2+ ionophore in cultured cells (33). As we show
here by Northern blot analysis with a rat MKP-1 cDNA probe, TRH
also stimulates the expression of MKP-1 (Fig.
1). TRH induction is as strong and rapid
as with the mitogenic stimulus EGF, which was used as a positive
control for MKP-1 induction. GH4C1 cells exposed to 100 nM
TRH showed maximally enhanced levels of MKP-1 mRNA as early as 30 min, followed by a rapid decline to lower but still significantly elevated levels at 60 min which were sustained up to 6 h. Slightly slower induction kinetics were observed for EGF, with MKP-1 mRNA levels peaking at 45 min (Fig. 1, A and B). After
more than 6 h of treatment, the level of MKP-1 mRNA was higher
for TRH-stimulated cells compared with EGF-treated cells, where the
MKP-1 message returned almost to the basal level (Fig. 1B).
GAPDH mRNA levels were not changed by either TRH or EGF stimulation
and can thus be used as an invariant internal control. Based on the
kinetics shown in Fig. 1, MKP-1 expression was assessed in all
subsequent experiments at 30 min after TRH or EGF stimulation.
To show that TRH- or EGF-induced MKP-1 mRNA accumulation is linked
to transcriptional activation of the gene, we analyzed the effect of
the transcriptional inhibitor actinomycin, added 30 min prior to a
further 30-min exposure to TRH or EGF. Actinomycin D (Act D)
completely suppressed MKP-1 mRNA induction by TRH and EGF (Fig.
1C, lanes 6 and 9). In
addition, the protein synthesis inhibitor cycloheximide
(CHX) did not prevent TRH or EGF induction of MKP-1,
confirming that MKP-1 is an immediate early gene. In contrast to what
was observed for other immediate early genes in GH cells (31),
cycloheximide, per se, did not induce MKP-1. Nor did
cycloheximide potentiate TRH or EGF induction of MKP-1 mRNA (Fig.
1C, lanes 3, 4,
7, and 10). Instead, cycloheximide treatment
lowered MKP-1 mRNA levels under stimulated conditions (compare
lanes 5 and 8 with lanes
7 and 10, respectively).
Induction of MKP-1 mRNA by TRH Depends upon Ca2+
Signaling, and Induction by EGF Does Not--
In GH4C1 cells, the
increase of [Ca2+]i stimulated by TRH consists of
two phases: an initial spike, due to intracellular Ca2+
store mobilization, followed by a "plateau phase" of enhanced action potential firing, causing spikes of
[Ca2+]i due to Ca2+ influx during
action potentials (34, 35). Previous reports have shown that the
prolonged phase of [Ca2+]i spiking was essential
to enhance and maintain proto-oncogene mRNA levels over time (31,
32, 36). To examine the role of Ca2+ influx in MKP-1
expression induced by TRH, GH4C1 cells were preincubated for 5 min in
serum-free medium containing 0.6 mM EGTA (free
[Ca2+]e <0.1 µM). This procedure
has little effect on the initial spike of [Ca2+]i
but prevents Ca2+ action potentials and the corresponding
Ca2+ influx (Refs. 32 and 36 and data not shown). To
establish unequivocally a role for Ca2+ signaling, the
induction of MKP-1 by TRH and EGF in the presence and absence of EGTA
were quantitatively assessed by RNase protection assays and by
quantitative RT-PCR.
As shown in Fig. 2A, the MKP-1
riboprobe (395 nucleotides) protects a 286-nucleotide (nt) fragment of
the MKP-1 mRNA in basal and stimulated conditions. The level of
MKP-1 induction was determined after normalization of the MKP-1 signal
to the signal of the protected fragment of GAPDH mRNA at 154 nt
(Fig. 2B). RNase protection assays with antisense 18 S RNA
and GAPDH confirmed that GAPDH mRNA levels did not change following
stimulation with either TRH or EGF in low extracellular
Ca2+ (data not shown). TRH induced a 10-fold elevation of
MKP-1 mRNA, which was reduced to 5-fold by inhibiting
Ca2+ influx. EGF, which raised MKP-1 mRNA to the same
levels as TRH, could still markedly stimulate MKP-1 mRNA
accumulation (8-fold) in the absence of free extracellular
Ca2+.
These results were confirmed by the analysis of the same RNA samples by
quantitative RT-PCR using primer pairs and probes specific for MKP-1
mRNA and the ribosomal 18 S RNA (see "Experimental Procedures")
(Fig. 2C). The MKP-1 mRNA level was determined after normalization to the level of 18 S RNA and then plotted as -fold induction over basal conditions (Fig. 2D). Both methods of
RNA analysis show very similar relative result when comparing data in
Fig. 2, B and D.
Taken together, the results show that a rise in
[Ca2+]i is essential for MKP-1 induction by TRH
but is not important for EGF; this is consistent with the fact that
Ca2+ is not involved in the signaling pathways triggered by
the EGF receptor.
Cloning of the Rat MKP-1 Gene and Identification of the
Transcriptional Initiation Site--
To elucidate the mechanisms
involved in Ca2+-dependent and
Ca2+-independent transcriptional activation of the
MKP-1 gene GH4C1 cells, we cloned and sequenced the rat
MKP-1 gene. The mouse and the human MKP-1 gene had been cloned
previously in other studies (6, 37). PCR was performed with GH4C1
genomic DNA and primers situated in two regions that are conserved in
the promoter and the exon 4 of the mouse and the human genes (see
"Experimental Procedures"). The sequence of the resulting 2892-bp
PCR fragment was 66% identical to the mouse MKP-1 gene. To verify that
this fragment corresponds to the rat MKP-1 gene and does not contain any repetitive sequences, Southern blotting was performed with GH4C1
genomic DNA digested with StuI or PvuII
restriction enzymes (Fig. 3A).
DNA probes corresponding to the region of the promoter or the introns
in the 2892-bp PCR fragment hybridize to the same band as the exon 1 probe and do not cross-react with other genomic DNA fragments. This
indicates that the different probes are specific for a single gene,
namely the rat MKP-1 sequence. Alignment of the rat, mouse, and human
MKP-1 sequences shows that the critical promoter elements identified in
the mouse and human promoters are conserved in the rat promoter (Fig.
3B).
To map the transcriptional start site in the rat gene, an antisense RNA
probe overlapping the TATA box and the MKP-1 ORF was designed. RNase
protection assays with total RNA from TRH-stimulated GH4C1 cells showed
two protected fragments: a major band at 183 nt and a minor band at 185 nt. The antisense DNA sequence starting at the MKP-1 ORF run in
parallel with the protected fragments allows us to determine the
position of initiation of transcription in the MKP-1 sequence (Fig.
3C). The two transcriptional start sites identified in the
rat MKP-1 gene are located at the same positions as those determined
for the mouse and the human gene, at 20 and 22 residues,
respectively, downstream of the consensus TATA sequence (Fig.
3B).
Limited Stimulation of Reporter Gene Expression Driven by the Rat
MKP-1 Promoter--
The search for regulatory elements involved in
Ca2+-dependent and Ca2+-independent
activation of MKP-1 transcription was started using a reporter gene
approach. The promoter region
As a further control, we compared the MKP-1 reporter construct with an
SV40 promoter construct and with a "c-fos/intron"
construct that contains the sequence from the promoter to exon 2 fused
to the ORF of the luciferase gene (25, 26). These reporter constructs were compared in basal and stimulated conditions with KCl plus cAMP,
TRH, or EGF (Table I). As reported
previously (25), expression of luciferase from the c-fos
construct is highly induced in all three stimulated conditions, whereas
with the MKP-1 promoter, stimulation is limited to a 1.5-1.7-fold
increase. Comparing the reporter data from the MKP-1 promoter with the
SV40 promoter constructs suggests that the MKP-1 promoter behaves very
much like a constitutive promoter in this cell line. This may indicate
that the 650-bp fragment of the rat MKP-1 gene contains sufficient
promoter elements to drive the expression of the reporter gene but
lacks control elements that restrict basal expression and thereby
permit strong activation both by Ca2+-dependent
(KCl plus cAMP; TRH) and Ca2+-independent (EGF) stimuli.
The discrepancy between the highly controlled endogenous expression of
MKP-1 (Fig. 2) and the lack of control by the same stimuli with the
reporter gene expression system (Fig. 4) suggests that important
regulatory steps may require elements that are not situated in the
promoter region, defined here between MKP-1 Transcription Is Controlled by a Calcium-sensitive Elongation
Block in the First Exon--
To analyze in more detail the
transcriptional control of MKP-1 and determine if the gene is also
regulated at steps different from initiation (e.g.
elongation), we performed nuclear run-on experiments with nuclei
isolated from GH4C1 cells after stimulation with TRH or EGF (Fig.
5). Nascent RNAs transcripts in nuclei
isolated from stimulated and nonstimulated cells were labeled by
in vitro elongation with [
A similar result was obtained with the c-fos oncogene in
nuclear run-on assays performed with GH4C1 nuclei (probes F and G, Fig.
5). The calcium dependent block to elongation in the intron 1 of
c-fos was previously described in neuroendocrine cells (25) and other cell lines (20-23).
To localize more precisely the block of elongation in the MKP-1 gene,
we prepared restriction fragments of the exon 1-intron 1 region and
used these probes to map the pause site by nuclear run-on assays.
Digested products were separated by gel electrophoresis, transferred to
a membrane, and hybridized with labeled RNAs isolated from nuclear
run-on reactions performed with basal or TRH-stimulated cells. DNA
fragment that does not hybridize in basal conditions but does hybridize
in the stimulated conditions indicates that the polymerase was blocked
before reaching the sequence corresponding to that DNA fragment. DNA
digested by SacII, NheI, and HindIII (Fig. 6A, lane
1) showed, after nuclear run-on in basal conditions, a
hybridized fragment SacII-NheI but not
SacII-HindIII (Fig. 6B, lane
1), indicating that the polymerase was blocked before reaching the
intron 1. DNA digested by NcoI, NheI, and
HindIII (Fig. 6A, lane 2) showed,
after nuclear run-on, that the three fragments NcoI-NheI, NcoI-NcoI, and
NcoI-HindIII are all hybridized by nascent RNA in
basal conditions (Fig. 6B, lane 2).
The weak signal corresponding to the NcoI-HindIII
fragment in basal condition suggests that RNA polymerase II has
transcribed part of the sequence between NcoI and
SacII but was blocked before entering intron 1. Taken together, these results show that the block of elongation in MKP-1 is
located in the exon 1 possibly in the first 300-400 nt of the 5'-end
of the gene. Further fine mapping by KMnO4 footprinting (18) and nuclear run-on performed with antisense oligonucleotide probes
(38) will permit us to determine if the block to transcriptional elongation correlates with promoter-proximal pauses sites and/or intrinsic sites of premature termination in the exon 1 of MKP-1.
This study identified a calcium-sensitive block to elongation
within the first exon of the rat MKP-1 gene as an important element for
transcription regulation. TRH strongly stimulates MKP-1 transcription
by enhancing initiation and elongation by Ca2+-sensitive
mechanisms. Stimulation by EGF resulted in a similar rise in MKP-1
transcription, based again on enhanced initiation and elongation but
(in contrast to TRH) without the need for Ca2+ signaling.
The involvement of a calcium-sensitive elongation block in MKP-1 gene
expression is reminiscent of c-fos expression for which a
block to elongation is an essential element (Fig. 6 and Refs. 20-23
and 25). This suggests that common mechanisms of intragenic regulation
may be conserved between MKP-1 and c-fos.
Change in MKP-1 and c-fos gene expression level, via
potential deregulation of the block to elongation, may have
physiological importance in tumorigenesis. For c-fos, it is
well known that this oncogene is up-regulated in several tumor cells
(e.g. 39-41). For MKP-1, several studies have shown an
overexpression of both the MKP-1 mRNA and protein at different
stages of breast and prostate carcinoma (42-45). These latter reports
have suggested that up-regulation of MKP-1 may contribute to tumor
growth by inactivating preferentially stress-activated MAP kinases
(stress-activated protein kinase/Jun N-terminal kinases, p38) that can
promote apoptosis in tumor cells exposed to toxic stimuli.
The dual specificity MAP kinase phosphatases, DSPs or MKPs,
inactivate MAP kinases by dual dephosphorylation. In turn, MKPs can be
controlled in at least three ways: first by subtype-specific enhancement of their catalytic activity triggered by direct interaction with MAP kinases (46, 47); second by MAP kinase phosphorylation (in the
case of MKP-1), which stabilizes the otherwise very labile protein
(48); and third by transcriptional activation of some MAP kinase
phosphatases (e.g. MKP-1 and MKP-2) encoding for
immediate early genes (4).
Transcription of the MKP-1 gene can be induced rapidly by multiple
intracellular signals, including active mitogenic or stress-activated MAP kinase cascades, protein kinase C, cAMP, and Ca2+
signals (5-10, 33). Prior to our study, the induction of the human
MKP-1 gene in HeLa cells, by the mitogenic stimuli EGF, fibroblast
growth factor, or platelet-derived growth factor, was thought to be
essentially mediated by activation through the promoter of the gene
(6).
In our quantitative study, we show a clear discrepancy between the
levels of induction for the MKP-1 mRNA and reporter gene assays
with the promoter of MKP-1. We observed an 18-fold stimulation of the
MKP-1 mRNA by TRH and EGF (Fig. 2D), which contrasts
with the 1.5- and 1.6-fold stimulation, respectively, of MKP-1 reporter gene expression from the promoter (Table I). This difference can have
two possible explanations: (i) chromatin structure influences the basal
activity of the gene and may tightly be regulated following stimulation, and (ii) further 5'- or 3'-end sequences not present in
the promoter construct may be important to control MKP-1 gene transcription. We showed (Fig. 5) that a controlled release of a block
to elongation in the exon 1 may explain part of this difference between
exogenous and endogenous expression of MKP-1. Although quantitative
data in reporter gene assays and nuclear run-on are not directly
comparable for technical reasons, the abundance of nascent transcripts
extending beyond the elongation block is enhanced 10-20-fold,
respectively, by TRH and EGF, with a concomitant increase of only
4-6-fold in early transcripts (signal A, Table II); this result is
again compatible with an important contribution of elongation control
to the transcriptional activation.
The transient transcriptional activation of MKP-1 by TRH and EGF
results in a significant enhancement of MKP-1 mRNA at 30 min (Fig.
1) but also at the protein level 1 h after stimulation (data not
shown). It becomes thus evident that a tight control of MKP-1 gene
transcription at the level of initiation and elongation, combined with
its differential binding and catalytic activation by specific MAP
kinases, provides a sophisticated mechanism for rapid and targeted
inactivation of selected MAP kinase cascades.
Calcium is a critical modulator of immediate early gene expression at
different levels in mammalian cells. In contrast to a number of studies
that examine the role of Ca2+ signaling by using
Ca2+ ionophores and other nonphysiologic stimuli, we
describe here the role of physiological Ca2+ signaling
triggered by the releasing factor TRH in MKP-1 gene expression. TRH
stimulates the release of Ca2+ from internal stores and
provokes a prolonged precisely patterned Ca2+ influx, due
to Ca2+ action potentials (34, 35). GH4C1 cells stimulated
by TRH in medium with low free extracellular Ca2+ result in
the suppression of sustained intracellular Ca2+ signals.
(32, 36). We demonstrated marked differences in MKP-1 gene expression
in the absence or presence of extracellular Ca2+ after TRH
stimulation, which defines a physiological role for calcium in MKP-1
induction associated with the release of the block to elongation. In
addition to Ca2+ signaling, TRH activates other pathways,
notably through cAMP and MAP kinases. The residual TRH effects seen for
MKP-1 transcription (Table II) in the absence of sustained
Ca2+ signaling are probably due to such additional pathways.
How does Ca2+ control MKP-1 gene transcription? Since very
few reports have studied the regulation of MKP-1 gene expression, we
can only speculate on responsive elements in the MKP-1 gene and relate
them to known functional determinants in other
Ca2+-regulated genes (e.g. c-fos).
First, considering homologies between the rat, mouse, and human MKP-1
promoters, we find two conserved CRE elements and one E box motif. The
CRE element and its binding protein CREB are known to mediate calcium
signals in the nucleus for several genes including the c-fos
oncogene. Ca2+-activated gene transcription is mediated
through phosphorylation of CREB and the CREB-binding protein by CaM
kinase IV. CREB phosphorylation is also a target for multiple signal
transduction pathways, which involve different activated protein
kinases (49). Thus Ca2+-, mitogenic, or stress-activated
MAP kinases may control MKP-1 transcription, as in c-fos,
through phosphorylation of CREB transcription factors at the level of
initiation. Consistent with this idea, Sommer et al. (10)
have reported that the upstream stimulatory factor that binds the E-box
motif in the promoter of MKP-1 cooperates with signals that stimulate
CRE-dependent transcription.
Other regulatory elements may be involved to control MKP-1
transcription by calcium. Recently, a Ca2+-regulated
transcriptional repressor (DREAM) that binds to the DRE element has
been show to control the transcriptional activity of the
c-fos oncogene (50). The DRE element in the human
c-fos oncogene is located at 20 nt downstream of the
transcriptional initiation site. A similar consensus DRE element is
located in the first 10 bp of the rat, mouse, and human MKP-1 gene that
could be a target for DREAM-mediated transcriptional repression.
Alternatively, Ca2+ regulation of MKP-1 gene transcription
may depend on transcription factors translocated to the nucleus by the
calcium-activated phosphatase calcineurin (51, 52) or on an alternative
Ca2+ signaling pathway sensitive to the calmodulin
antagonist W7. Coulon et al. (23) have reported that this
latter calcium signaling pathway affects the intragenic regulation of
c-fos expression via suppression of a transcriptional pause site.
In summary, we have identified a novel gene, MKP-1, which is regulated
at the level of elongation of transcription in a manner similar to the
c-fos oncogene. While the mechanisms that control transcriptional elongation remain relatively unclear, MKP-1 gene expression studies conducted in parallel with the analysis of a similar
phenomenon in c-fos expression are certainly useful to
further advance our knowledge of the regulation of transcriptional elongation in eukaryotes and on immediate early gene expression in
mammalian cells.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
display a strong block to transcriptional
elongation in the promoter-proximal region (13-16). Characterization
of the block in vivo, by either nuclear run-on or
KMnO4 footprinting, showed that promoter-proximal pause
sites in c-fos, c-myc, and hsp70 are important
for controlling RNA polymerase II processivity (15, 17-19). In the
case of c-fos, an additional transcriptional pause site is
located in the first intron of this oncogene that is sensitive to
Ca2+ stimulation (17, 20-23). The precise mechanism of
intronic regulation of c-fos by Ca2+ signals is
not known.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
80 °C. EGTA (Fluka Chemie) was diluted in
H2O and stored at room temperature as 100 mM
stock solution (pH 7.5). Actinomycin D (Sigma) and cycloheximide (Sigma) were diluted respectively in EtOH and Me2SO at 5 and 10 mg/ml and stored at 4 °C. CPT-cAMP (Roche Molecular
Biochemicals) was diluted in H2O, stored in aliquots at
20 °C at a concentration of 10 mM. KCl (Fluka Chemie)
was diluted in H2O and stored 4 °C at a concentration of
3 M.
-32P]CTP-labeled cDNA probes
obtained by random priming. The probes used correspond to the
SacII (position 40)-MunI (position 789) fragment of the rat MKP-1 cDNA (GenBankTM accession
number X84004) subcloned in the plasmid pBSK(
) and to a fragment of
1.22 kilobase pairs of the mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA subcloned in pBSK(
).
INS-1 and rat
vascular smooth muscle cells. The cloned GH4C1 sequence is available in
the GenBankTM data base with the accession number
AF357203.
-32P]CTP
DNA probes amplified by PCR and corresponding to regions of the
promoter, exon 1, or the introns in the 2892-bp PCR fragment: probe 1 (
631 to +2), 2 (+25 to +464), 3 (+464 to +824), 4 (+840 to +1469),
and 5 (+1454 to +1903).
631 to +19 between the KpnI and
NheI restriction sites of the pGL3 enhancer vector
(Promega). Plasmid pSV40 was obtained by subcloning the SV40 promoter
from the pGL3-control vector (+49 to +244) between the KpnI
and NheI restriction sites of the pGL3 enhancer vector. The
"c-fos/intron" construction was previously described
elsewhere (25, 26).
80 °C until use. Nuclear run-on
was carried out as described by Collart et al. (27). After
in vitro elongation, the same amount of labeled RNA from
each reaction was hybridized to the pBSK(
) plasmid containing different DNA inserts from the rat MKP-1 locus: A (position +25 to
SacII (+464)), B (SacII (+464) to SpeI
(+824)), C (+840 to +1469), D (+1454 to +1903), E (StuI
(+1854) to +2237), which had been immobilized on a N+-nylon
membrane. Mouse c-fos oncogene fragments F (+53 to +764) and
G (+418 to +1130), cloned in pBSK(
), were also blotted on the same
membrane. pBSK(
) and GAPDH cDNA (+1 to +1220), subcloned in
pBSK(
), were spotted and used, respectively, as a control for
hybridization and an invariant internal control. Blots were developed
by autoradiography and quantified with a Molecular Dynamics PhosphorImager.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (23K):
[in a new window]
Fig. 1.
Rapid induction of MKP-1 mRNA by TRH and
EGF in pituitary GH4C1 cells depends on transcriptional
activation. A, serum-depleted (24 h) GH4C1 cells were
stimulated with TRH (100 nM) or EGF (10 nM) for
the indicated times. 10 µg of total RNA were analyzed by Northern
blotting using [
-32P]CTP-labeled cDNA probes for
MKP-1 and GAPDH, as described under "Experimental Procedures."
B, time course of MKP-1 mRNA induction by TRH and EGF;
PhosphorImager data obtained from Northern blotting analysis performed
as in A were normalized for GAPDH and presented as -fold
induction over basal levels. C, effect of actinomycin D
(Act D; 5 µg/ml) and cycloheximide (CHX; 10 µg/ml) added 30 min prior to stimulation by TRH and EGF on MKP-1
mRNA levels; recorded 30 min after stimulation by Northern blot
analysis, as in A.

View larger version (25K):
[in a new window]
Fig. 2.
Induction by TRH of MKP-1 mRNA depends
upon Ca2+ signaling; induction
by EGF does not. After stimulation of GH4C1 cells with TRH and EGF
under experimental conditions that do or do not allow Ca2+
signaling, MKP-1 mRNA levels were quantitatively assessed as
follows. A, RNase protection assay of total RNA from GH4C1
cells isolated after 30 min of stimulation with either TRH or EGF.
Where indicated, 0.6 mM EGTA was added 5 min before
stimulation. 20 µg of total RNA were co-hybridized to two
[
-32P]UTP RNA probes for MKP-1 and GAPDH, as described
under "Experimental Procedures" and digested with RNase A and T1.
Free probes, protected fragments, and the RNA CenturyTM
size marker (Ambion) were resolved on a 6% polyacrylamide sequencing
gel. B, quantification by PhosphorImager of the RNA levels
detected by RNase protection in A (±S.E., n = 6). C, example of quantitative RT-PCR amplification
records obtained for MKP-1 (upper panel) and 18 S
mRNA (lower panel) under basal and
TRH-stimulated conditions. Multiplex quantitative PCR amplification
(TaqMan; PerkinElmer Life Sciences) was performed using
sequence-specific primer pairs and probes corresponding to the junction
of exons 1-2 of MKP-1 and to the transcribed region of the ribosomal
18 S RNA as described under "Experimental Procedures." Threshold
cycle values are indicated by circles. D, average
(±S.E., n = 10) MKP-1 mRNA levels derived from
threshold cycle values obtained in sextuplicate and plotted standard
curves for MKP-1 were normalized for 18 S mRNA levels and then
expressed as -fold induction over basal values.

View larger version (70K):
[in a new window]
Fig. 3.
Cloning of the promoter and the introns of
the rat MKP-1 gene and identification of the transcriptional initiation
site. A, the rat MKP-1 gene was amplified by PCR,
cloned, and sequenced (GenBankTM accession number
AF357203), as described under "Experimental Procedures." The cloned
fragment of 2.9 kilobase pairs was used to prepare random labeled DNA
probes (probes 1-5) for Southern analysis. GH4C1 genomic DNA fragments
obtained by either StuI or PvuII digestion were
separated on a 0.7% agarose gel, blotted onto a Nylon N+
membrane, and hybridized to random labeled DNA probes corresponding to
the promoter, exon 1, or intron 1, 2, or 3 of rat MKP-1. Smart Ladder
(Eurogentec) size markers are shown in the first
lane. B, conservation of the MKP-1 promoter
sequences between rat, mouse, and human. Shown is multiple sequence
alignment with ClustalW of the rat MKP-1 (GenBankTM
accession number AF357203) with the mouse MKP-1 (GenBankTM
accession number S64851) (36) and the human MKP-1
(GenBankTM accession number U01669) (6). Identical
nucleotides are shown with asterisks, and the conserved DNA
binding motif CREs, E box, and the TATA box are
underlined in the sequence. The transcriptional start sites
are indicated by arrows; gray arrows
indicate the sites found in rat MKP-1 (Fig. 3B), the
open arrow indicates the potential start site of
the mouse MKP-1 (36), and filled arrows indicate
the human MKP-1 sites mapped by Kwak et al. (6) and Sommer
et al. (10). C, the transcriptional start site of
the rat MKP-1 was mapped by RNase protection (lane
2). Total RNA from TRH-stimulated GH4C1 cells was hybridized
to the rat antisense MKP-1 probe corresponding to the genomic sequence
from +172 to
34. The hybrid was digested by RNase A and T1, and the
protected fragment was resolved on a 6% polyacrylamide sequencing gel
run in parallel with the reaction products obtained from the MKP-1
antisense DNA sequenced with a primer starting at position +172. The
200-base RNA CenturyTM size marker (Ambion) is shown in
lane 1.
631 to +19 of the rat MKP-1 gene was
inserted into a luciferase reporter vector. GH4C1 cells were
transiently transfected and subsequently stimulated with a variety of
agonists. As shown in Fig. 4, luciferase
expression obtained with this construct was already high under
unstimulated basal conditions and only marginally (<2-fold) increased
following stimulation of the GH4C1 cells by KCl plus cAMP, TRH, or EGF. The lack of induction was not due to saturation of the system, since we
obtained similar results in cells transfected with lower plasmid
concentrations, and a linear relation was observed between plasmid
concentration and luciferase expression in the range of concentrations
used routinely (data not shown).

View larger version (18K):
[in a new window]
Fig. 4.
Limited stimulation of reporter gene
expression driven by the rat MKP-1 promoter. Reporter gene assay
with the promoter of rMKP-1. GH4C1 cells were transiently transfected
with a firefly luciferase reporter vector comprising the region
631
to +19 of the rat MKP-1 promoter and a Renilla luciferase
control vector. Cells were tansfected using FuGENE (Roche Molecular
Biochemicals) and incubated for 24 h in a medium with serum. Then
the medium was replaced with serum-free medium for another 24 h of
incubation. The cells were stimulated for 3 h with KCl (20 mM), CPT-cAMP (33 µM), both KCl and CPT-cAMP,
TRH (100 nM), or EGF (10 nM). Cell extracts
were analyzed for firefly and Renilla luciferase activities
using the corresponding cofactors. Reporter luciferase activity was
normalized to constitutive Renilla luciferase expression in
the same extracts and is shown as the average ratio between the RLUs
obtained (±S.E., n = 3). The relative -fold induction
of this construct in different conditions of stimulation is showed in
Table I.
631 and +19.
Quantification of MKP-1 promoter activity in GH4C1: comparison with the
SV40 promoter and with the c-fos/intron constructs
631 to +19 of the rat MKP-1
gene; pSV40 contains the promoter SV40 of the pGL3-control vector
(Promega); and the c-fos/intron construct comprises the
region of the mouse c-fos oncogene from the promoter to exon
2 fused to the ORF of the luciferase reporter gene. The transcriptional
activity of this construct in GH4C1 was previously described elsewhere
(25).
-32P]UTP,
purified, and hybridized to unlabeled DNA fragments spotted on a
membrane. These fragments include sequences spread out along the MKP-1
gene (Fig. 5, A-E), two fragments (F and
G) corresponding to exon 1 and intron 1 of the mouse
c-fos oncogene, the GAPDH gene as a control of
transcription, and pBSK as a negative control (see "Experimental
Procedures"). As shown in Fig. 5, MKP-1 transcription is initiated
under basal conditions (signal in A, lane
1) but does not proceed to the end of the gene. The
polymerase is blocked at the exon 1-intron 1 junction. When cells are
stimulated with TRH or EGF (lanes 2 and
4), the block to elongation is released, and MKP-1 gene
transcription is completed (signal in E). To determine the
effect of Ca2+ signals on the block of elongation in MKP-1
gene transcription, nuclear run-on assays were performed with cells
stimulated with TRH or EGF in low extracellular Ca2+. The
addition of 0.6 mM of EGTA prior to TRH stimulation
decreases transcription efficiency at the level of the first intron
(probes B and D) more than in the first exon (probe A); the ratios B/A and D/A are significantly reduced by EGTA in TRH-stimulated conditions (Table II, bottom). This indicates
that TRH-induced Ca2+ signals are important to release the
block of elongation. Stimulation with EGF in the presence or absence of
EGTA both activate MKP-1 transcription at the level of initiation and
elongation. A quantitative analysis of these results is shown in Table
II. The signals for fragments A-E were corrected for U content and
normalized to the signal of GAPDH (Table II, top). By comparing the
signal intensities (as -fold induction over basal condition) observed
in nuclear run-on assays, for the probes A, B, and D, with the level of
induction of MKP-1 messenger measured by RNase protection assays or
TaqMan (Fig. 2), we show that for any condition of stimulation, the
level of induction for the probes B and D is similar to the one
observed for the MKP-1 mRNA (Table II, bottom). The rise of
initiation of transcription under stimulated conditions (monitored on
signal A) is not sufficient to account for the level of induction of the MKP-1 mRNA. Additional activation of elongation is
necessary to maximally stimulate MKP-1 gene expression. These results
together with those reported in Fig. 4 suggest that MKP-1 transcription is controlled by a constitutively active promoter and that a major contribution to gene transcription is conferred by a strong block of
elongation within the gene.

View larger version (28K):
[in a new window]
Fig. 5.
Identification of a calcium-sensitive
elongation block in the region exon 1-intron 1 of the MKP-1 gene.
GH4C1 cells were stimulated or not (basal) for 25 min with TRH (100 nM) or EGF (10 nM). When indicated, 0.6 mM EGTA was added 5 min prior to stimulation to
chelate-free calcium in the medium. After isolation of the nuclei and
nuclear run-on transcription, labeled RNAs were hybridized to DNA
fragments spotted on a membrane. Fragments A-E correspond to the rat
MKP-1 gene; fragments F and G correspond to the c-fos
oncogene, pBSK, and GAPDH cDNA. Extension of the probes A-G is
presented on the MKP-1 and c-fos genomic maps; a precise
description is given under "Experimental Procedures." Shown is a
typical experiment, repeated five times for basal, TRH, and TRH/EGTA
conditions and three times for EGF and EGF/EGTA conditions.
Quantitative analysis of these data is presented in Table II.
Quantification of transcriptional activity within the MKP-1 locus in
neuroendocrine cells: effect of calcium
0.05. NS, not significant.
Quantitation of the transcriptional activity within the
c-fos locus (fragment F and G, Fig. 5) is described
elsewhere (25).

View larger version (30K):
[in a new window]
Fig. 6.
The block to elongation is
localized in exon 1 of the MKP-1 gene. A, plasmid pGL3
with the insert +2 to +748 of rMKP-1 was digested with
NheI/HindIII and then with SacII
(lane 1) or NcoI (lane
2) to generate subfragments of the 5'-end. 4 µg of the
digested DNA were run on a 0.7% agarose gel with a 100-bp DNA ladder
(lane M). Respective restriction fragments
generated are indicated on the map of the MKP-1 exon 1-intron 1 locus.
B, Southern blot of A. Restriction fragments with
SacII (1) or NcoI (2) were
transferred on a Nylon-N+ membrane. The membranes were
hybridized with labeled RNAs obtained by in vitro elongation
using nuclei isolated from GH4C1 cells stimulated or not (basal) with
100 nM TRH as in nuclear run-on experiments (Fig. 5).
Hybridization signals obtained in basal conditions, indicating RNA
transcripts upstream of the block to elongation (indicated with
solid arrows) correspond to
NcoI-NcoI, NcoI-NheI, and
SacII-NheI fragments; hybridization signals from
SacII-HindIII and
NcoI-HindIII fragments (indicated by
dashed arrows) are only obtained following
release of the elongation block by TRH and indicate transcripts
downstream of the elongation block site. Quantification of the
hybridization signals by film densitometry and normalized for U content
gave the following arbitrary values: SacII-NheI
(1450 versus 2460), SacII-HindIII (260 versus 1320); NheI-NcoI plus
NcoI-NcoI (720 versus 1067), and
NcoI-HindIII (150 versus 1220) for
basal versus TRH stimulated cell nuclei, respectively.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank I. Piuz, A. Massiha, and A. Maturana for excellent technical assistance and M. A. Collart, M. Strubin, W. Reith, W. L. Kelley, and N. Demaurex for discussions and critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by the Swiss National Science Foundation Grants 3200-050879.97/1 and 32-61833.00 and by the Fondation pour Recherches Médicales.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF357203.
§ Present address: Serono Reproductive Biology Institute, Randolph, MA.
¶ Present address: Dept. of Medicine, University of Texas Health Science Center, San Antonio, TX.
To whom correspondence should be addressed: Fondation pour
Recherche Médicales, 64 av. de la Roseraie, University of Geneva, 1211 Geneva, Switzerland. Tel.: 41-22-3823811; Fax: 41-22-3475979; E-mail: werner.schlegel@medecine.unige.ch.
Published, JBC Papers in Press, June 22, 2001, DOI 10.1074/jbc.M102326200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: IEG, immediate early gene; MKP-1, mitogen-activated protein kinase phosphatase-1; TRH, thyrotropin-releasing hormone; EGF, epidermal growth factor; MAP, mitogen-activated protein; CRE, cAMP-responsive element; CREB, CRE-binding protein; SFM, serum-free medium; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; bp, base pair(s); PCR, polymerase chain reaction; PCR, polymerase chain reaction; RT-PCR, reverse transcription-PCR; PBS, phosphate-buffered saline; GH, growth hormone; ORF, open reading frame.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Herschman, H. R. (1991) Annu. Rev. Biochem. 60, 281-319 |
| 2. | Sheng, M., and Greenberg, M. E. (1990) Neuron 4, 477-485 |
| 3. | Camps, M., Nichols, A., and Arkinstall, S. (1999) FASEB J. 14, 6-16 |
| 4. | Keyse, S. M. (2000) Curr. Opin. Cell Biol. 12, 186-192 |
| 5. | Charles, C. H., Abler, A. S., and Lau, L. F. (1992) Oncogene 7, 187-190 |
| 6. | Kwak, S. P., Hakes, D. J., Martell, K. J., and Dixon, J. E. (1994) J. Biol. Chem. 269, 3596-3604 |
| 7. | Guo, Y. L., Kang, B., and Williamson, J. R. (1998) J. Biol. Chem. 273, 10362-10366 |
| 8. | Keyse, S. M., and Emslie, E. A. (1992) Nature 359, 644-647 |
| 9. | Laderoute, K. R., Mendonca, H. L., Calaoagan, J. M., Knapp, A. M., Giaccia, A. J., and Stork, P. J. (1999) J. Biol. Chem. 274, 12890-12897 |
| 10. | Sommer, A., Burkhardt, H., Keyse, S. M., and Luscher, B. (2000) FEBS Lett. 474, 146-150 |
| 11. | Spencer, C. A., and Groudine, M. (1990) Oncogene 5, 777-785 |
| 12. | Uptain, S. M., Kane, C. M., and Chamberlin, M. J. (1997) Annu. Rev. Biochem. 66, 117-172 |
| 13. | Fort, P., Rech, J., Vie, A., Piechaczyk, M., Bonnieu, A., Jeanteur, P., and Blanchard, J. M. (1987) Nucleic Acids Res. 15, 5657-5667 |
| 14. | Bentley, D. L., and Groudine, M. (1986) Nature 321, 702-706 |
| 15. | Brown, S. A., Imbalzano, A. N., and Kingston, R. E. (1996) Genes Dev. 10, 1479-1490 |
| 16. | Biragyn, A., and Nedospasov, S. A. (1995) J. Immunol. 155, 674-683 |
| 17. | Plet, A., Eick, D., and Blanchard, J. M. (1995) Oncogene 10, 319-328 |
| 18. | Pinaud, S., and Mirkovitch, J. (1998) J. Mol. Biol. 280, 785-798 |
| 19. | Strobl, L. J., and Eick, D. (1992) EMBO J. 11, 3307-3314 |
| 20. | Collart, M. A., Tourkine, N., Belin, D., Vassalli, P., Jeanteur, P., and Blanchard, J. M. (1991) Mol. Cell. Biol. 11, 2826-2831 |
| 21. | Werlen, G., Belin, D., Conne, B., Roche, E., Lew, D. P., and Prentki, M. (1993) J. Biol. Chem. 268, 16596-16601 |
| 22. | Lee, G., and Gilman, M. (1994) Mol. Cell. Biol. 14, 4579-4587 |
| 23. | Coulon, V., Veyrune, J. L., Tourkine, N., Vie, A., Hipskind, R. A., and Blanchard, J. M. (1999) J. Biol. Chem. 274, 30439-30446 |
| 24. | Fort, P., Marty, L., Piechaczyk, M., el Sabrouty, S., Dani, C., Jeanteur, P., and Blanchard, J. M. (1985) Nucleic Acids Res. 13, 1431-1442 |
| 25. | van Haasteren, G., Li, S., Ryser, S., and Schlegel, W. (2000) Neuroendocrinology 72, 368-378 |
| 26. | Susini, S., Van Haasteren, G., Li, S., Prentki, M., and Schlegel, W. (2000) FASEB J. 14, 128-136 |
| 27. | Collart, M. A., Belin, D., Vassalli, J. D., and Vassalli, P. (1987) J. Immunol. 139, 949-955 |
| 28. | Tashjian, A. H. (1979) Methods Enzymol. 58, 527-535 |
| 29. | Gourdji, D., C., T., and A., T.-V. (1982) Front. Neuroendocrinol. 7, 317-357 |
| 30. | Carr, F. E., Fisher, C. U., Fein, H. G., and Smallridge, R. C. (1993) Endocrinology 133, 1700-1707 |
| 31. | Passegue, E., Richard, J. L., Boulla, G., and Gourdji, D. (1995) Mol. Cell. Endocrinol. 107, 29-40 |
| 32. | Li, S. L., Godson, C., Roche, E., Zhao, S. J., Prentki, M., and Schlegel, W. (1994) J. Mol. Endocrinol. 13, 303-312 |
| 33. | Scimeca, J. C., Servant, M. J., Dyer, J. O., and Meloche, S. (1997) Oncogene 15, 717-725 |
| 34. | Schlegel, W., and Wollheim, C. B. (1984) J. Cell Biol. 99, 83-87 |
| 35. | Schlegel, W., Winiger, B. P., Mollard, P., Vacher, P., Wuarin, F., Zahnd, G. R., Wollheim, C. B., and Dufy, B. (1987) Nature 329, 719-721 |
| 36. | Li, S. L., Cougnon, N., Bresson-Bepoldin, L., Zhao, S. J., and Schlegel, W. (1996) J. Mol. Endocrinol. 16, 229-238 |
| 37. | Noguchi, T., Metz, R., Chen, L., Mattei, M. G., Carrasco, D., and Bravo, R. (1993) Mol. Cell. Biol. 13, 5195-5205 |
| 38. | Eick, D., Kohlhuber, F., Wolf, D. A., and Strobl, L. J. (1994) Anal. Biochem. 218, 347-351 |
| 39. | Urabe, A., Nakayama, J., Tanigushi, S., Terao, H., and Hori, Y. (1992) J. Pathol. 168, 281-286 |
| 40. | Biunno, I., Pozzi, M. R., Pierotti, M. A., Pilotti, S., Cattoretti, G., and Della, P. G. (1988) Br. J. Cancer 57, 464-468 |
| 41. | Walker, R. A., and Cowl, J. (1991) J. Pathol. 163, 323-327 |
| 42. | Leav, I., Magi-Galluzzi, C., Ziar, J., Stork, P. J. S., Ho, S., and Loda, M. (1996) Lab. Invest. 75, 361-370 |
| 43. | Loda, M., Capodieci, P., Mishra, R., Yao, H., Corless, C., Grigioni, W., Wang, Y., Magi-Galluzzi, C., and Stork, P. J. (1996) Am. J. Pathol. 149, 1553-1564 |
| 44. | Magi-Galluzzi, C., Mishra, R., Fiorentino, M., Montironi, R., Yao, H., Capodieci, P., Wishnow, K., Kaplan, I., Stork, P. J., and Loda, M. (1997) Lab. Invest. 76, 37-51 |
| 45. | Magi-Galluzzi, C., Montironi, R., Cangi, M. G., Wishnow, K., and Loda, M. (1998) Virchows Arch. 432, 407-413 |
| 46. | Camps, M., Nichols, A., Gillieron, C., Antonsson, B., Muda, M., Chabert, C., Boschert, U., and Arkinstall, S. (1998) Science 280, 1262-1265 |
| 47. | Hutter, D., Chen, P., Barnes, J., and Liu, Y. (2000) Biochem. J. 352, 155-163 |
| 48. | Brondello, J. M., Pouyssegur, J., and McKenzie, F. R. (1999) Science 286, 2514-2517 |
| 49. | De Cesare, D., Fimia, G. M., and Sassone-Corsi, P. (1999) Trends Biochem. Sci. 24, 281-285 |
| 50. | Carrion, A. M., Link, W. A., Ledo, F., Mellstrom, B., and Naranjo, J. R. (1999) Nature 398, 80-84 |
| 51. | Lim, H. W., New, L., Han, J., and Molkentin, J. D. (2001) J. Biol. Chem. 276, 15913-15919 |
| 52. | Crabtree, G. R. (2001) J. Biol. Chem. 276, 2313-2316 |
This article has been cited by other articles:
![]() |
A. D. Maturana, S. Walchli, M. Iwata, S. Ryser, J. Van Lint, M. Hoshijima, W. Schlegel, Y. Ikeda, K. Tanizawa, and S. Kuroda Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel Cardiovasc Res, March 25, 2008; (2008) cvn052v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujita, S. Ryser, I. Piuz, and W. Schlegel Up-Regulation of P-TEFb by the MEK1-Extracellular Signal-Regulated Kinase Signaling Pathway Contributes to Stimulated Transcription Elongation of Immediate Early Genes in Neuroendocrine Cells Mol. Cell. Biol., March 1, 2008; 28(5): 1630 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Pennington, B. J. Foster, S. R. Hawley, R. E. Jenkins, O. Zolle, M. R. H. White, C. J. McNamee, P. Sheterline, and A. W. M. Simpson Cell Shape-dependent Control of Ca2+ Influx and Cell Cycle Progression in Swiss 3T3 Fibroblasts J. Biol. Chem., November 2, 2007; 282(44): 32112 - 32120. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Casal, S. Ryser, A. M. Capponi, and C. F. Wang-Buholzer Angiotensin II-Induced Mitogen-Activated Protein Kinase Phosphatase-1 Expression in Bovine Adrenal Glomerulosa Cells: Implications in Mineralocorticoid Biosynthesis Endocrinology, November 1, 2007; 148(11): 5573 - 5581. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Tephly and A. B. Carter Differential Expression and Oxidation of MKP-1 Modulates TNF-{alpha} Gene Expression Am. J. Respir. Cell Mol. Biol., September 1, 2007; 37(3): 366 - 374. [Abstract] [Full Text] [PDF] |
||||